glp 1 アゴニスト Impact of GLP- Receptor Agonist Therapy in Patients High Risk for Sarcopenia | Current Nutrition Reports GLP-1受容体作動薬市場規模・シェアレポート（2032年）

Combined deficiencies of NADPH- and NADH-dependent dihydropyrimidine dehydrogenases, a new finding in a family with thymine-uraciluria

Systematic review: Clinical evidence of probiotics in the prevention of antibiotic-associated diarrhoea

This work was supported and funded by Kuwait University Research Project No

Perioperative insulin resistance and stress hyperglycemia are common after major surgery and are associated with oxidative stress and organ injury

CCL-11 or Eotaxin-1: an immune marker for ageing and accelerated ageing in neuro-psychiatric disorders

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, Phase 2 trial